Collplant Biotechnologies Stock Price Patterns
| CLGN Stock | USD 0.70 0.06 9.37% |
Momentum 65
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.12) | EPS Estimate Current Year (0.98) | EPS Estimate Next Year (0.41) | Wall Street Target Price 11.12 | EPS Estimate Current Quarter 0.155 |
Using Collplant Biotechnologies hype-based prediction, you can estimate the value of Collplant Biotechnologies from the perspective of Collplant Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Collplant Biotechnologies using Collplant Biotechnologies' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Collplant using crowd psychology based on the activity and movement of Collplant Biotechnologies' stock price.
Collplant Biotechnologies Implied Volatility | 1.08 |
Collplant Biotechnologies' implied volatility exposes the market's sentiment of Collplant Biotechnologies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Collplant Biotechnologies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Collplant Biotechnologies stock will not fluctuate a lot when Collplant Biotechnologies' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Collplant Biotechnologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Collplant because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Collplant Biotechnologies after-hype prediction price | USD 0.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Collplant | Build AI portfolio with Collplant Stock |
Collplant Biotechnologies After-Hype Price Density Analysis
As far as predicting the price of Collplant Biotechnologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Collplant Biotechnologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Collplant Biotechnologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Collplant Biotechnologies Estimiated After-Hype Price Volatility
In the context of predicting Collplant Biotechnologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Collplant Biotechnologies' historical news coverage. Collplant Biotechnologies' after-hype downside and upside margins for the prediction period are 0.04 and 10.11, respectively. We have considered Collplant Biotechnologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Collplant Biotechnologies is dangerous at this time. Analysis and calculation of next after-hype price of Collplant Biotechnologies is based on 3 months time horizon.
Collplant Biotechnologies Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Collplant Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Collplant Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Collplant Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.16 | 9.27 | 0.14 | 0.30 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.70 | 0.84 | 20.00 |
|
Collplant Biotechnologies Hype Timeline
Collplant Biotechnologies is currently traded for 0.70. The entity has historical hype elasticity of 0.14, and average elasticity to hype of competition of -0.3. Collplant is forecasted to increase in value after the next headline, with the price projected to jump to 0.84 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 20.0%, whereas the daily expected return is currently at -1.16%. The volatility of related hype on Collplant Biotechnologies is about 3538.17%, with the expected price after the next announcement by competition of 0.40. Collplant Biotechnologies currently holds 3.08 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Collplant Biotechnologies has a current ratio of 15.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Collplant Biotechnologies' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Collplant Biotechnologies Basic Forecasting Models to cross-verify your projections.Collplant Biotechnologies Related Hype Analysis
Having access to credible news sources related to Collplant Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Collplant Biotechnologies' future price movements. Getting to know how Collplant Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Collplant Biotechnologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NRXS | Neuraxis | (0.54) | 4 per month | 3.85 | 0.18 | 7.88 | (5.86) | 38.80 | |
| ENLV | Enlivex Therapeutics | 0.01 | 7 per month | 4.38 | 0.05 | 8.57 | (8.16) | 24.21 | |
| NRSN | Neurosense Therapeutics | (0.02) | 7 per month | 4.76 | 0.01 | 12.82 | (7.48) | 34.62 | |
| XCUR | Exicure | (0.18) | 8 per month | 8.47 | 0.05 | 21.22 | (11.88) | 63.80 | |
| KLTO | Klotho Neurosciences | 0.00 | 5 per month | 0.00 | (0.16) | 10.34 | (10.00) | 29.02 | |
| CVKD | Cadrenal Therapeutics Common | (0.46) | 9 per month | 0.00 | (0.14) | 8.11 | (8.29) | 58.15 | |
| SONN | Sonnet Biotherapeutics Holdings | (0.58) | 8 per month | 0.00 | (0.02) | 19.48 | (18.21) | 69.59 | |
| RLYB | Rallybio Corp | (0.18) | 6 per month | 3.44 | (0.02) | 6.57 | (6.08) | 19.36 | |
| TAOX | TAO Synergies | 0.04 | 17 per month | 0.00 | (0.14) | 11.74 | (10.43) | 33.82 | |
| MTVA | MetaVia | (0.71) | 8 per month | 0.00 | (0.20) | 11.60 | (20.10) | 79.95 |
Collplant Biotechnologies Additional Predictive Modules
Most predictive techniques to examine Collplant price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Collplant using various technical indicators. When you analyze Collplant charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Collplant Biotechnologies Predictive Indicators
The successful prediction of Collplant Biotechnologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Collplant Biotechnologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Collplant Biotechnologies based on analysis of Collplant Biotechnologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Collplant Biotechnologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Collplant Biotechnologies's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 13.09 | 413.19 | 475.17 | 634.32 | PTB Ratio | 2.57 | 3.06 | 2.76 | 4.63 |
Pair Trading with Collplant Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collplant Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Collplant Stock
Moving against Collplant Stock
| 0.64 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.45 | DSGN | Design Therapeutics | PairCorr |
| 0.39 | ENGN | enGene Holdings Common | PairCorr |
| 0.33 | KYTX | Kyverna Therapeutics | PairCorr |
The ability to find closely correlated positions to Collplant Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collplant Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collplant Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collplant Biotechnologies to buy it.
The correlation of Collplant Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collplant Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collplant Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Collplant Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Collplant Biotechnologies Basic Forecasting Models to cross-verify your projections. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Will Biotechnology sector continue expanding? Could Collplant diversify its offerings? Factors like these will boost the valuation of Collplant Biotechnologies. Projected growth potential of Collplant fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Collplant Biotechnologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth 18.25 | Return On Assets | Return On Equity |
Investors evaluate Collplant Biotechnologies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Collplant Biotechnologies' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Collplant Biotechnologies' market price to deviate significantly from intrinsic value.
It's important to distinguish between Collplant Biotechnologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Collplant Biotechnologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Collplant Biotechnologies' market price signifies the transaction level at which participants voluntarily complete trades.